Malic Acid

Malic Acid

SCHEMBL217490

O=C(O)CC(O)C(=O)O.[Zr]

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CACNA1CCACNA1DCACNA1FCACNA1SDRD2HTR1BHTR1DHTR1F

The experimentally established mechanism targets of Malic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.94
▸ SLC22A6 Q4U2R8 1/20 0.53
▸ TET2 Q6N021 6/20 0.52
▸ TET3 O43151 2/20 0.52
▸ TET1 Q8NFU7 1/20 0.52
▸ KDM4A O75164 2/20 0.50
▸ KDM4C Q9H3R0 2/20 0.50
▸ KDM2A Q9Y2K7 2/20 0.50
▸ OR51E2 Q9H255 1/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ GABRR1 P24046 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ KMO O15229 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Malic Acid SCHEMBL711844 0.97 SMN1; SMN2 (0.88) SMN1; SMN2SLC22A6TET2TET3TET1
Malic Acid SCHEMBL31673489 0.97 — —
Malic Acid SCHEMBL89131 0.97 SMN1; SMN2 (1.00) SMN1; SMN2SLC22A6TET2TET3TET1
Malic Acid SCHEMBL29410671 0.97 SMN1; SMN2 (1.00) SMN1; SMN2SLC22A6TET2TET3TET1
Malic Acid SCHEMBL98496 0.97 — —
Malic Acid SCHEMBL31673494 0.97 — —
Malic Acid SCHEMBL256122 0.97 — —
Malic Acid SCHEMBL14125844 0.97 SMN1; SMN2 (1.00) SMN1; SMN2SLC22A6TET2TET3TET1
Malic Acid SCHEMBL856 0.97 — —
Malic Acid SCHEMBL28355917 0.97 SMN1; SMN2 (1.00) SMN1; SMN2SLC22A6TET2TET3TET1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 885 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11649709-B2 Polymer blends for stimulation of oil and gas wells Energy Solutions (US) LLC (US) 2023-05-16 — — US claimed
US-20220348820-A1 CROSSLINKED PROPPANT-GEL MATRIX HEXION INC. 2022-11-03 — — US claimed
US-11459885-B2 Workflow for predictive model to select formation damage treatment HALLIBURTON ENERGY SERVICES, INC. (US) 2022-10-04 — — US claimed
US-11447689-B2 Crosslinked proppant-gel matrix HEXION INC. (US) 2022-09-20 — — US claimed
CN-109863221-B Polymer blends for stimulation of oil and gas wells 罗地亚经营管理公司 2021-12-24 — — CN claimed
US-20210207464-A1 POLYMER BLENDS FOR STIMULATION OF OIL & GAS WELLS RHODIA OPERATIONS (FR) 2021-07-08 — — US claimed
US-10982519-B2 Polymer blends for stimulation of oil and gas wells RHODIA OPERATIONS (FR) 2021-04-20 — — US claimed
US-20210095186-A1 CROSSLINKED PROPPANT-GEL MATRIX HEXION INC. 2021-04-01 — — US claimed
US-10883041-B2 Crosslinked proppant-gel matrix HEXION INC. (US) 2021-01-05 — — US claimed
EP-3512918-A1 POLYMER BLENDS FOR STIMULATION OF OIL&GAS WELLS Rhodia Operations (FR) 2019-07-24 — — EP claimed
US-7297665-B2 Fluids comprising zirconium isopropylamine crosslinking agents and associated methods HALLIBURTON ENERGY SERVICES, INC. (US) 2007-11-20 — — US claimed
US-7225874-B2 Methods and compositions for reducing the viscosity of treatment fluids used in subterranean operations HALLIBURTON ENERGY SERVICES, INC. (US) 2007-06-05 — — US claimed
US-7205264-B2 Well treatment method using fluid containing lactic acid or salt thereof BJ SERVICES COMPANY (US) 2007-04-17 — — US claimed
WO-2007020390-A1 METHODS AND COMPOSITIONS FOR REDUCING THE VISCOSITY OF TREATMENT FLUIDS USED IN SUBTERRANEAN OPERATIONS HALLIBURTON ENERGY SERVICES, INC. (US) 2007-02-22 — — WO claimed
US-20070034376-A1 Providing a treatment fluid that comprises an aqueous base fluid and a gelling agent; providing a breaker that comprises a hydroquinone component; allowing the breaker to interact with the treatment fluid; and allowing the breaker to at least partially reduce the viscosity of the treatment fluid HALLIBURTON ENERGY SERVICES, INC. 2007-02-15 — — US claimed
US-20070037713-A1 Comprises a gelling agent, the breaker comprising a hydroquinone component and an additional breaker component HALLIBURTON ENERGY SERVICES, INC. 2007-02-15 — — US claimed
WO-2006117517-A2 ACIDIC TREATMENT FLUIDS COMPRISING SCLEROGLUCAN AND/OR DIUTAN AND ASSOCIATED METHODS HALLIBURTON ENERGY SERVICES, INC. (US) 2006-11-09 — — WO claimed
US-20060247135-A1 Acidic treatment fluids comprising scleroglucan and/or diutan and associated methods HALLIBURTON ENERGY SERVICES, INC. 2006-11-02 — — US claimed
US-20060229213-A1 Fluids comprising zirconium isopropylamine crosslinking agents and associated methods HALLIBURTON ENERGY SERVICES, INC. 2006-10-12 — — US claimed
US-20040152602-A1 Crosslinking delaying agents for acid fluids BAKER HUGHES HOLDINGS LLC 2004-08-05 — — US claimed
Send feedback